| 37972955 | LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera Valeda Light Delivery System. | Retina | 2024 |
| 37972955 | LIGHTSITE III: 13-Month Efficacy and Safety Evaluation of Multiwavelength Photobiomodulation in Nonexudative (Dry) Age-Related Macular Degeneration Using the Lumithera Valeda Light Delivery System. | Retina | 2024 |
| 36588113 | LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration. | Ophthalmol Ther | 2023 |
| 36588113 | LIGHTSITE II Randomized Multicenter Trial: Evaluation of Multiwavelength Photobiomodulation in Non-exudative Age-Related Macular Degeneration. | Ophthalmol Ther | 2023 |
| 36366886 | Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial. | Lancet | 2022 |
| 36366886 | Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial. | Lancet | 2022 |
| 31404033 | A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION. | Retina | 2020 |
| 31404033 | A DOUBLE-MASKED, RANDOMIZED, SHAM-CONTROLLED, SINGLE-CENTER STUDY WITH PHOTOBIOMODULATION FOR THE TREATMENT OF DRY AGE-RELATED MACULAR DEGENERATION. | Retina | 2020 |
| 27989012 | Photobiomodulation reduces drusen volume and improves visual acuity and contrast sensitivity in dry age-related macular degeneration. | Acta Ophthalmol | 2017 |
| 28169294 | Factors predictive of survival and estimated years of life lost in the decade following nontraumatic and traumatic spinal cord injury. | Spinal Cord | 2017 |
| 27989012 | Photobiomodulation reduces drusen volume and improves visual acuity and contrast sensitivity in dry age-related macular degeneration. | Acta Ophthalmol | 2017 |
| 28169294 | Factors predictive of survival and estimated years of life lost in the decade following nontraumatic and traumatic spinal cord injury. | Spinal Cord | 2017 |
| 26816218 | TIMP2â¿¢IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients. | J Trauma Acute Care Surg | 2016 |
| 26816218 | TIMP2â¿¢IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients. | J Trauma Acute Care Surg | 2016 |
| 25590604 | Validation of a multiprotein plasma classifier to identify benign lung nodules. | J Thorac Oncol | 2015 |
| 25884949 | Cell signaling-based classifier predicts response to induction therapy in elderly patients with acute myeloid leukemia. | PLoS One | 2015 |
| 25590604 | Validation of a multiprotein plasma classifier to identify benign lung nodules. | J Thorac Oncol | 2015 |
| 25884949 | Cell signaling-based classifier predicts response to induction therapy in elderly patients with acute myeloid leukemia. | PLoS One | 2015 |
| 24559465 | Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. | Am J Respir Crit Care Med | 2014 |
| 25237065 | Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. | Nephrol Dial Transplant | 2014 |
| 24559465 | Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. | Am J Respir Crit Care Med | 2014 |
| 25237065 | Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. | Nephrol Dial Transplant | 2014 |
| 22299818 | Transcranial laser therapy for acute ischemic stroke: a pooled analysis of NEST-1 and NEST-2. | Int J Stroke | 2013 |
| 22299818 | Transcranial laser therapy for acute ischemic stroke: a pooled analysis of NEST-1 and NEST-2. | Int J Stroke | 2013 |
| 23565191 | SMA-MAP: a plasma protein panel for spinal muscular atrophy. | PLoS One | 2013 |
| 23388612 | Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. | Crit Care | 2013 |
| 23660846 | Transcranial laser therapy and infarct volume. | Stroke | 2013 |
| 23660846 | Transcranial laser therapy and infarct volume. | Stroke | 2013 |
| 23388612 | Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. | Crit Care | 2013 |
| 23565191 | SMA-MAP: a plasma protein panel for spinal muscular atrophy. | PLoS One | 2013 |
| 21795588 | IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-β in multiple sclerosis. | Sci Transl Med | 2011 |
| 21795588 | IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-β in multiple sclerosis. | Sci Transl Med | 2011 |
| 19233936 | Effectiveness and safety of transcranial laser therapy for acute ischemic stroke. | Stroke | 2009 |
| 19233936 | Effectiveness and safety of transcranial laser therapy for acute ischemic stroke. | Stroke | 2009 |